Acuta Capital Partners’s Oculis Holding OCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.61M Sell
98,339
-3,438
-3% -$91K 1.84% 14
2025
Q4
$2.03M Hold
101,777
1.38% 17
2025
Q3
$1.79M Sell
101,777
-4,941
-5% -$87.6K 1.85% 16
2025
Q2
$2.07M Sell
106,718
-18,282
-15% -$336K 2.89% 12
2025
Q1
$2.38M Buy
+125,000
New +$2.56M 2.76% 12

Other funds holding OCS

Acuta Capital Partners's OCS Position: Q1 2026 in Review

Acuta Capital Partners reduced its Oculis Holding (OCS) stake by 3.4% in Q1 2026, selling an estimated $91K and leaving 98,339 shares worth $2.61M. The position accounts for 1.84% of the portfolio, ranked #14.

Acuta Capital Partners first reported a position in OCS in Q1 2025 and has held it in 5 quarters since. 57 funds tracked by Wall St. Rank hold OCS as of Q1 2026.

  • Acuta Capital Partners held 98,339 shares of Oculis Holding worth $2.61M as of Q1 2026.
  • Acuta Capital Partners sold 3,438 Oculis Holding shares in Q1 2026, an estimated $91K.
  • Oculis Holding made up 1.84% of Acuta Capital Partners's portfolio in Q1 2026, its #14 holding.
  • Acuta Capital Partners first reported a position in Oculis Holding in Q1 2025 and has held it in 5 quarters since.
  • 57 funds tracked by Wall St. Rank held Oculis Holding as of Q1 2026.

Based on Acuta Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.